{"hands_on_practices": [{"introduction": "Understanding a signal transduction pathway is akin to tracing a cascade of falling dominoes. To truly grasp its logic, one must be able to predict what happens when a key component is permanently altered. This exercise challenges you to do just that by considering a plant with a constitutively stabilized Ethylene Insensitive 3 (EIN3) protein, a master transcription factor near the end of the ethylene signaling pathway. By reasoning through the consequences of locking this crucial step in the \"on\" state, this practice [@problem_id:2566796] will sharpen your ability to apply pathway logic, a critical skill for interpreting the results of genetic experiments and understanding the flow of cellular information.", "problem": "A plant physiology lab constructs a transgenic climacteric fruit crop line (for example, tomato) that overexpresses a mutant form of Ethylene Insensitive 3 (EIN3) whose primary degradation motifs recognized by EIN3-Binding F-box proteins (EBF1/2) are disrupted, rendering the protein constitutively stabilized. Leaves and fruits from this line are examined alongside wild type controls under two treatments: an ethylene biosynthesis inhibitor aminoethoxyvinylglycine (AVG) and an ethylene receptor blocker 1-methylcyclopropene (1-MCP). All tissues are grown under otherwise non-stress conditions.\n\nUse the following foundational facts as the starting point for your reasoning:\n- In the absence of ethylene, ethylene receptors (for example, Ethylene Response 1, ETR1) activate Constitutive Triple Response 1 (CTR1), a Raf-like kinase that suppresses Ethylene Insensitive 2 (EIN2) signaling, and EIN3/EIN3-Like (EIL) transcription factors are kept at low abundance by EBF1/2-mediated proteasomal degradation.\n- In the presence of ethylene, receptors are inactivated, CTR1 inhibition is relieved, EIN2 signaling promotes the degradation of EBF1/2 and stabilization of EIN3/EILs, which then activate Ethylene Response Factor (ERF) genes and ethylene-responsive programs, including leaf senescence and climacteric fruit ripening.\n- Ethylene can positively regulate its own biosynthesis in climacteric fruit via induction of 1-aminocyclopropane-1-carboxylate synthase (ACS) and ACC oxidase (ACO), forming a feedback loop during the climacteric burst.\n\nPredict the most likely phenotypic and molecular outcomes in the stabilized EIN3 overexpression line, relative to wild type, for leaf senescence and fruit ripening under AVG and 1-MCP treatments. Choose the single best option.\n\nA. Constitutive activation of senescence- and ripening-associated transcriptional programs, leading to precocious leaf chlorophyll loss and upregulation of senescence-associated genes, as well as accelerated fruit softening and carotenoid accumulation, even when treated with AVG or 1-MCP; ethylene-responsive targets (for example, ERFs, ACS, and ACO) are upregulated due to active EIN3, potentially amplifying endogenous ethylene, but upstream blockade has little suppressive effect because signaling is bypassed.\n\nB. Global delay of senescence and ripening due to negative feedback, where stabilized EIN3 reduces ethylene biosynthesis, causing diminished ethylene levels; AVG and 1-MCP further delay phenotypes by preventing any residual ethylene action.\n\nC. No appreciable change in senescence or ripening timing because receptor kinases and CTR1 dominate pathway output; stabilized EIN3 remains functionally inert without ethylene, and 1-MCP blocks any downstream activation.\n\nD. Hypersensitivity to ethylene that still strictly requires ethylene perception, such that phenotypes manifest only when ethylene is present; AVG and 1-MCP fully suppress both senescence and ripening in the transgenic line despite EIN3 stabilization.", "solution": "The problem statement must first be validated for scientific soundness, self-consistency, and clarity before a solution is attempted.\n\n**Step 1: Extract Givens**\n-   **System**: A transgenic climacteric fruit crop line.\n-   **Genetic Modification**: Overexpression of a mutant Ethylene Insensitive 3 (EIN3) protein.\n-   **Protein Mutation**: The primary degradation motifs on EIN3, which are recognized by EIN3-Binding F-box proteins (EBF1/2), have been disrupted.\n-   **Result of Mutation**: The mutant EIN3 protein is constitutively stabilized.\n-   **Experimental Setup**: The transgenic line is compared to a wild type control. Tissues examined are leaves and fruits.\n-   **Treatments**:\n    1.  Aminoethoxyvinylglycine (AVG), an inhibitor of ethylene biosynthesis.\n    2.  1-methylcyclopropene (1-MCP), a blocker of ethylene receptors.\n-   **Foundational Principles of Ethylene Signaling**:\n    1.  **Absence of Ethylene**: Ethylene receptors (e.g., ETR1) activate Constitutive Triple Response 1 (CTR1). CTR1 suppresses Ethylene Insensitive 2 (EIN2) signaling. EIN3/EIN3-Like (EIL) transcription factors are kept at low levels via EBF1/2-mediated proteasomal degradation.\n    2.  **Presence of Ethylene**: Receptors are inactivated, relieving inhibition of CTR1. This leads to activation of EIN2. EIN2 promotes the degradation of EBF1/2 and stabilization of EIN3/EILs. EIN3/EILs activate downstream ethylene-responsive genes, including Ethylene Response Factors (ERFs), leading to senescence and ripening.\n    3.  **Positive Feedback**: In climacteric fruit, ethylene signaling can induce the expression of ethylene biosynthesis genes, 1-aminocyclopropane-1-carboxylate synthase (ACS) and ACC oxidase (ACO).\n\n**Step 2: Validate Using Extracted Givens**\nThe problem presents a classic genetic experiment based on the well-established canonical pathway for ethylene signal transduction in plants. The components mentioned (ETR1, CTR1, EIN2, EIN3, EBF1/2) and their described interactions are consistent with current scientific understanding of plant physiology. The genetic modification—stabilizing a key transcription factor by removing its degradation signal—is a standard molecular biology technique to probe pathway function. The chemical inhibitors, AVG and 1-MCP, are standard tools in this field. The question asks for a logical deduction of the phenotypic and molecular consequences based on these premises. The problem is scientifically grounded, well-posed, and objective. It contains no contradictions, ambiguities, or factual errors.\n\n**Step 3: Verdict and Action**\nThe problem statement is valid. A solution will be derived.\n\n**Derivation of Solution**\n\nThe core of the problem lies in understanding the position and function of EIN3 within the signaling cascade and the consequence of its constitutive stabilization.\n\n1.  **Normal Pathway Regulation**: In a wild type plant, the entire signaling pathway exists to regulate the abundance of the EIN3 protein. The chain of events is: Ethylene perception $\\rightarrow$ Receptor inactivation $\\rightarrow$ CTR1 inactivation $\\rightarrow$ EIN2 activation $\\rightarrow$ EBF1/2 degradation $\\rightarrow$ EIN3 stabilization and accumulation. EIN3 is the terminal master transcription factor in this cascade that directly activates ethylene response genes. Its activity is primarily controlled by its presence or absence, which is determined by proteasomal degradation mediated by EBF1/2.\n\n2.  **Effect of the Transgenic Modification**: The transgenic line expresses a form of EIN3 that cannot be degraded by EBF1/2 because its recognition sites are removed. Furthermore, this mutant protein is overexpressed. This means a high concentration of stable, and therefore active, EIN3 protein will be present in the nucleus at all times. This condition is known as a constitutive activation of the pathway. The regulation of all upstream components (receptors, CTR1, EIN2, EBF1/2) becomes irrelevant to the final output, as the final step (activation by EIN3) is now permanently \"on\".\n\n3.  **Phenotypic and Molecular Prediction**:\n    -   Because active EIN3 is always present, it will constitutively bind to the promoters of its target genes and activate their transcription. These targets include genes responsible for leaf senescence (e.g., senescence-associated genes, or SAGs) and climacteric fruit ripening (e.g., genes for cell wall degradation like polygalacturonase, and pigment synthesis like phytoene synthase).\n    -   This will result in phenotypes that mimic a continuous ethylene treatment: precocious leaf senescence (e.g., premature chlorophyll loss) and accelerated fruit ripening (e.g., rapid softening and accumulation of carotenoids like lycopene in tomato).\n    -   The specified upstream inhibitors, AVG and 1-MCP, will be ineffective. AVG blocks ethylene synthesis, and 1-MCP blocks ethylene perception at the receptors. Both act at the very beginning of the pathway. Since the genetic modification bypasses these initial steps by creating a constitutively active component downstream, blocking the upstream signal will not prevent the downstream response.\n    -   According to the provided facts, EIN3 also activates the genes for ethylene biosynthesis, ACS and ACO. Therefore, the constitutive activity of the mutant EIN3 will lead to the upregulation of these genes, causing the plant to produce large amounts of its own ethylene. This creates a positive feedback loop that amplifies the response, but the crucial point is that the initial activation of the pathway is ethylene-independent.\n\n**Evaluation of Options**\n\n-   **A. Constitutive activation of senescence- and ripening-associated transcriptional programs, leading to precocious leaf chlorophyll loss and upregulation of senescence-associated genes, as well as accelerated fruit softening and carotenoid accumulation, even when treated with AVG or 1-MCP; ethylene-responsive targets (for example, ERFs, ACS, and ACO) are upregulated due to active EIN3, potentially amplifying endogenous ethylene, but upstream blockade has little suppressive effect because signaling is bypassed.**\n    This option accurately describes constitutive activation of the pathway, leading to precocious senescence and accelerated ripening. It correctly states that these phenotypes are insensitive to AVG and 1-MCP because the signaling cascade is bypassed downstream of the inhibitors' targets. It also correctly identifies the molecular mechanism, including upregulation of target genes like ERFs, ACS, and ACO, and the resulting amplification loop. This aligns perfectly with the derived solution. **Verdict: Correct.**\n\n-   **B. Global delay of senescence and ripening due to negative feedback, where stabilized EIN3 reduces ethylene biosynthesis, causing diminished ethylene levels; AVG and 1-MCP further delay phenotypes by preventing any residual ethylene action.**\n    This option predicts a delay, which is the opposite of the expected outcome. The premise that stabilized EIN3 *reduces* ethylene biosynthesis contradicts the foundational fact that ethylene signaling *induces* it. This statement is fundamentally incorrect. **Verdict: Incorrect.**\n\n-   **C. No appreciable change in senescence or ripening timing because receptor kinases and CTR1 dominate pathway output; stabilized EIN3 remains functionally inert without ethylene, and 1-MCP blocks any downstream activation.**\n    This option incorrectly assumes that the upstream components (receptors, CTR1) remain dominant despite the genetic modification. The central error is the claim that stabilized EIN3 is \"functionally inert without ethylene.\" The established model is that EIN3 stability is the primary point of regulation for its activity. A stabilized EIN3 is an active EIN3. Therefore, bypassing this regulation will lead to a strong, not absent, phenotype. **Verdict: Incorrect.**\n\n-   **D. Hypersensitivity to ethylene that still strictly requires ethylene perception, such that phenotypes manifest only when ethylene is present; AVG and 1-MCP fully suppress both senescence and ripening in the transgenic line despite EIN3 stabilization.**\n    This option confuses a *constitutive* phenotype with a *hypersensitive* one. A hypersensitive mutant would show an exaggerated response to a small amount of signal, but would still require the signal. A constitutive mutant, which is what is described here, shows the response even in the complete absence of the signal. The claim that AVG and 1-MCP would fully suppress the phenotype is therefore incorrect, as the need for ethylene perception has been bypassed. **Verdict: Incorrect.**", "answer": "$$\\boxed{A}$$", "id": "2566796"}, {"introduction": "After exploring the pathway's logic, we can quantify its behavior. A central question in physiology is: how much of a signal is required to elicit a given response? This is typically characterized by a dose-response curve, from which the half-maximal effective concentration ($EC_{50}$) is determined as a standard measure of sensitivity. This problem [@problem_id:2566802] challenges you to derive the fundamental mathematical relationship between ethylene concentration and physiological output from the law of mass action, and then apply this model to calculate the $EC_{50}$ from experimental data, effectively bridging molecular theory with organism-level measurements.", "problem": "A laboratory quantifies the ethylene-induced triple response in etiolated seedlings by measuring a normalized triple-response index, denoted $T$, that ranges from $0$ (no response in the absence of ethylene) to $1$ (maximal response at saturating ethylene). Consider that ethylene binds to a single class of receptor sites on the endoplasmic reticulum with one-to-one stoichiometry, and that binding inactivates the receptor and thereby increases downstream signaling. Assume mass-action binding at equilibrium, and assume that downstream signaling output is linearly proportional to the fraction of receptors bound by ethylene. Under these assumptions, the concentration of ethylene, denoted $[E]$, controls $T$ through the fraction of receptors bound. The half-maximal effective concentration (EC$_{50}$) is the ethylene concentration at which $T = 0.5$.\n\nYou are given dose–response measurements for wild type (WT) and for a dominant ethylene receptor mutant (M) that reduces apparent affinity for ethylene. The dynamic range has been normalized so that the minimum is $0$ and the maximum is $1$ for both genotypes. Assume negligible experimental error. The data are:\n\n- WT: at $[E] = 0.50$ $\\mu$L L$^{-1}$, $T = 0.333$; at $[E] = 2.00$ $\\mu$L L$^{-1}$, $T = 0.667$.\n- M: at $[E] = 2.00$ $\\mu$L L$^{-1}$, $T = 0.286$; at $[E] = 10.0$ $\\mu$L L$^{-1}$, $T = 0.667$.\n\nStarting from the mass-action equilibrium for one-to-one receptor–ligand binding and the stated proportionality between signaling output and bound fraction, derive the algebraic relationship between $T$, $[E]$, and the half-maximal effective concentration $\\mathrm{EC}_{50}$, and then use the provided measurements to estimate $\\mathrm{EC}_{50}$ for WT and for M. Finally, compute the fold change in $\\mathrm{EC}_{50}$ for M relative to WT, defined as $\\mathrm{EC}_{50}^{\\mathrm{M}} / \\mathrm{EC}_{50}^{\\mathrm{WT}}$. Express the final fold change as a pure number (unitless) and round your answer to three significant figures.", "solution": "The problem as stated is scientifically grounded, well-posed, and objective. The assumptions of one-to-one stoichiometric binding, mass-action equilibrium, and linear proportionality of signal to receptor occupancy are standard for deriving dose-response relationships in pharmacology and biochemistry. The provided data are sufficient and consistent for estimating the required parameters. The problem is valid.\n\nThe first step is to derive the algebraic relationship between the normalized triple-response index $T$, the ethylene concentration $[E]$, and the half-maximal effective concentration $\\mathrm{EC}_{50}$.\n\nLet $R$ represent the ethylene receptor, $E$ represent the ethylene ligand, and $RE$ represent the ethylene-receptor complex. The binding reaction is a reversible equilibrium with one-to-one stoichiometry:\n$$R + E \\rightleftharpoons RE$$\nAccording to the law of mass action, the dissociation constant, $K_d$, is given by:\n$$K_d = \\frac{[R][E]}{[RE]}$$\nwhere $[R]$, $[E]$, and $[RE]$ are the molar concentrations of the free receptor, free ethylene, and the receptor-ethylene complex at equilibrium, respectively.\n\nThe total concentration of receptors, $[R]_{\\text{tot}}$, is the sum of the concentrations of the free and bound forms:\n$$[R]_{\\text{tot}} = [R] + [RE]$$\nThe fraction of receptors bound by ethylene, which we denote as $\\theta$, is:\n$$\\theta = \\frac{[RE]}{[R]_{\\text{tot}}}$$\nWe must express $\\theta$ as a function of $[E]$ and $K_d$. From the equation for total receptors, we have $[R] = [R]_{\\text{tot}} - [RE]$. Substituting this into the expression for $K_d$:\n$$K_d = \\frac{([R]_{\\text{tot}} - [RE])[E]}{[RE]}$$\nRearranging this equation to solve for the fraction $\\theta$:\n$$K_d [RE] = ([R]_{\\text{tot}} - [RE])[E] = [R]_{\\text{tot}}[E] - [RE][E]$$\n$$[RE](K_d + [E]) = [R]_{\\text{tot}}[E]$$\n$$\\frac{[RE]}{[R]_{\\text{tot}}} = \\frac{[E]}{K_d + [E]}$$\nThus, the fraction of bound receptors is:\n$$\\theta = \\frac{[E]}{K_d + [E]}$$\nThe problem states that the downstream signaling output is linearly proportional to the fraction of bound receptors. The normalized response index $T$ ranges from $0$ (no response, corresponding to $\\theta=0$) to $1$ (maximal response, corresponding to $\\theta=1$). This normalization implies that $T$ is directly equal to the fraction of bound receptors, $\\theta$.\n$$T = \\theta = \\frac{[E]}{K_d + [E]}$$\nThe half-maximal effective concentration, $\\mathrm{EC}_{50}$, is defined as the concentration $[E]$ at which the response $T$ is $0.5$. By substituting $T=0.5$ and $[E] = \\mathrm{EC}_{50}$ into our derived equation:\n$$0.5 = \\frac{\\mathrm{EC}_{50}}{K_d + \\mathrm{EC}_{50}}$$\n$$0.5(K_d + \\mathrm{EC}_{50}) = \\mathrm{EC}_{50}$$\n$$0.5 K_d + 0.5 \\mathrm{EC}_{50} = \\mathrm{EC}_{50}$$\n$$0.5 K_d = 0.5 \\mathrm{EC}_{50} \\implies K_d = \\mathrm{EC}_{50}$$\nTherefore, the dissociation constant $K_d$ is equivalent to the $\\mathrm{EC}_{50}$ under these assumptions. Substituting $\\mathrm{EC}_{50}$ for $K_d$ gives the final required relationship:\n$$T = \\frac{[E]}{\\mathrm{EC}_{50} + [E]}$$\nThis is a standard form of the Hill equation with a Hill coefficient of $1$.\n\nNext, we must estimate $\\mathrm{EC}_{50}$ for the wild type (WT) and mutant (M) genotypes using the provided data. We first rearrange the equation to solve for $\\mathrm{EC}_{50}$:\n$$T(\\mathrm{EC}_{50} + [E]) = [E]$$\n$$T \\cdot \\mathrm{EC}_{50} = [E] - T[E] = [E](1-T)$$\n$$\\mathrm{EC}_{50} = [E] \\frac{1-T}{T} = [E] \\left( \\frac{1}{T} - 1 \\right)$$\nThe problem states \"assume negligible experimental error\". The provided decimal values for $T$ appear to be rounded representations of simple fractions. We will assume these are exact rational numbers, as this interpretation leads to perfectly consistent results for both data points for each genotype, which is congruent with the premise of no error.\n\nFor the wild type (WT):\nThe data are ($[E]=0.50$, $T=0.333$) and ($[E]=2.00$, $T=0.667$). We interpret $T=0.333$ as $T=\\frac{1}{3}$ and $T=0.667$ as $T=\\frac{2}{3}$.\nUsing the first data point:\n$$\\mathrm{EC}_{50}^{\\mathrm{WT}} = 0.50 \\left( \\frac{1}{1/3} - 1 \\right) = 0.50(3-1) = 0.50(2) = 1.00 \\text{ } \\mu\\text{L L}^{-1}$$\nUsing the second data point:\n$$\\mathrm{EC}_{50}^{\\mathrm{WT}} = 2.00 \\left( \\frac{1}{2/3} - 1 \\right) = 2.00(1.5-1) = 2.00(0.5) = 1.00 \\text{ } \\mu\\text{L L}^{-1}$$\nBoth data points yield the identical value, so we conclude $\\mathrm{EC}_{50}^{\\mathrm{WT}} = 1.00$ $\\mu$L L$^{-1}$.\n\nFor the mutant (M):\nThe data are ($[E]=2.00$, $T=0.286$) and ($[E]=10.0$, $T=0.667$). We interpret $T=0.286$ as $T=\\frac{2}{7}$ (since $\\frac{2}{7} \\approx 0.2857$) and $T=0.667$ as $T=\\frac{2}{3}$.\nUsing the first data point:\n$$\\mathrm{EC}_{50}^{\\mathrm{M}} = 2.00 \\left( \\frac{1}{2/7} - 1 \\right) = 2.00(3.5-1) = 2.00(2.5) = 5.00 \\text{ } \\mu\\text{L L}^{-1}$$\nUsing the second data point:\n$$\\mathrm{EC}_{50}^{\\mathrm{M}} = 10.0 \\left( \\frac{1}{2/3} - 1 \\right) = 10.0(1.5-1) = 10.0(0.5) = 5.00 \\text{ } \\mu\\text{L L}^{-1}$$\nBoth data points yield the identical value, so we conclude $\\mathrm{EC}_{50}^{\\mathrm{M}} = 5.00$ $\\mu$L L$^{-1}$.\n\nFinally, we compute the fold change in $\\mathrm{EC}_{50}$ for M relative to WT:\n$$\\text{Fold Change} = \\frac{\\mathrm{EC}_{50}^{\\mathrm{M}}}{\\mathrm{EC}_{50}^{\\mathrm{WT}}} = \\frac{5.00 \\text{ } \\mu\\text{L L}^{-1}}{1.00 \\text{ } \\mu\\text{L L}^{-1}} = 5.00$$\nThe result is a pure number. The problem requires rounding to three significant figures, which is already satisfied by $5.00$.", "answer": "$$\n\\boxed{5.00}\n$$", "id": "2566802"}, {"introduction": "This final practice synthesizes genetic principles with quantitative modeling to investigate the molecular basis of genetic dominance. Ethylene receptors are negative regulators that function as dimers, and their composition can be altered by mutations. This exercise presents a scenario involving a mixed population of wild-type and dominant gain-of-function mutant receptors, which remain suppressive even when ethylene is present. This advanced problem [@problem_id:2566784] requires you to build a predictive model from first principles, combining the probabilities of random dimerization with ligand binding kinetics to calculate the resulting shift in ethylene sensitivity. Mastering this task demonstrates a sophisticated understanding of how molecular genetics ultimately shapes organismal physiology.", "problem": "Ethylene receptors in plants act as negative regulators of downstream responses: in the absence of ethylene, receptor dimers are active and suppress signaling; ethylene binding inactivates the dimers and lifts suppression. Consider a receptor population in which receptors function as dimers assembled by random association of monomers from a large pool. A fraction $q$ of monomers carry a dominant gain-of-function (GOF) allele that renders the receptor subunit constitutively active and insensitive to ethylene; the remaining fraction $1 - q$ are wild-type. Assume each subunit has one ethylene-binding site and that ligand binding obeys the Law of Mass Action with dissociation constant $K_d$ at concentration $x$. Assume further that a dimer is inactivated by ethylene if and only if it is a wild-type homodimer and at least one of its two binding sites is occupied by ethylene; any dimer containing at least one GOF subunit remains active regardless of ethylene presence.\n\nAssume the downstream physiological response is linearly proportional to the absolute fraction of inactivated dimers in the total receptor population. Define the ethylene concentration $x_{\\mathrm{wt}}$ in a wild-type receptor pool ($q = 0$) that produces a fixed absolute response threshold equal to $0.40$ of the total dimer population inactivated. Now consider a mixed receptor pool with $q = 0.30$ GOF monomers, and define $x_{\\mathrm{mix}}$ as the ethylene concentration that produces the same absolute response threshold (i.e., the same absolute fraction $0.40$ of the total dimer population inactivated).\n\nUsing only the above assumptions and starting from the Law of Mass Action and random dimerization, compute the fold-shift factor $F = x_{\\mathrm{mix}}/x_{\\mathrm{wt}}$. Express your final answer as a pure number, rounded to three significant figures. No units are required for the fold-shift.", "solution": "The problem statement has been subjected to validation and is deemed valid. It is scientifically grounded in the principles of molecular biology and chemical kinetics, well-posed with sufficient information for a unique solution, and expressed in objective, formal language. We may proceed with the solution.\n\nThe problem requires us to compute a fold-shift factor for ethylene concentration needed to achieve a specific response threshold in two different receptor populations. The physiological response is stated to be linearly proportional to the absolute fraction of inactivated dimers. A fixed response threshold therefore corresponds to a fixed absolute fraction of inactivated dimers. Let us denote this fraction by $I$. The problem specifies this threshold fraction is $0.40$.\n\nFirst, we must model the composition of the dimer population. Monomers are of two types: wild-type (WT) with fraction $1-q$ and dominant gain-of-function (GOF) with fraction $q$. Assuming random association, the fractions of the three possible dimer types are given by binomial probabilities:\n- Fraction of WT-WT homodimers: $P(\\text{WT-WT}) = (1-q)^2$\n- Fraction of GOF-GOF homodimers: $P(\\text{GOF-GOF}) = q^2$\n- Fraction of WT-GOF heterodimers: $P(\\text{WT-GOF}) = 2q(1-q)$\n\nThe problem states that a dimer is inactivated if and only if it is a wild-type homodimer and at least one of its two binding sites is occupied by ethylene. Any dimer containing at least one GOF subunit is constitutively active. This means only the WT-WT dimer population can contribute to the pool of inactivated receptors.\n\nNext, we model the binding of ethylene to a single binding site. According to the Law of Mass Action for a reversible reaction $S+E \\rightleftharpoons SE$, where $S$ is the binding site and $E$ is ethylene at concentration $x$, the dissociation constant is $K_d = \\frac{[S][E]}{[SE]}$. The probability that a site is occupied by ethylene, $p_{occ}$, is the fraction of bound sites, $\\frac{[SE]}{[S]+[SE]}$. By substituting $[SE] = \\frac{[S]x}{K_d}$, we find:\n$$p_{occ}(x) = \\frac{\\frac{[S]x}{K_d}}{[S] + \\frac{[S]x}{K_d}} = \\frac{\\frac{x}{K_d}}{1 + \\frac{x}{K_d}} = \\frac{x}{K_d + x}$$\nConsequently, the probability that a single site is unoccupied is:\n$$p_{unocc}(x) = 1 - p_{occ}(x) = 1 - \\frac{x}{K_d + x} = \\frac{K_d}{K_d + x}$$\nA WT-WT dimer has two independent binding sites. It is active if both sites are unoccupied. The probability of this state is $(p_{unocc}(x))^2$. The dimer is inactivated if at least one site is occupied. The probability of a WT-WT dimer being inactivated, conditional on its type, is therefore:\n$$P(\\text{inactivated}|\\text{WT-WT}, x) = 1 - (p_{unocc}(x))^2 = 1 - \\left(\\frac{K_d}{K_d + x}\\right)^2$$\nThe total fraction of inactivated dimers in the entire population, $I(x, q)$, is the product of the fraction of WT-WT dimers and their inactivation probability:\n$$I(x, q) = P(\\text{WT-WT}) \\times P(\\text{inactivated}|\\text{WT-WT}, x) = (1-q)^2 \\left[1 - \\left(\\frac{K_d}{K_d + x}\\right)^2\\right]$$\nWe are given a fixed response threshold corresponding to an absolute inactivated fraction of $I=0.40$.\n\nCase 1: Wild-type receptor pool.\nHere, $q=0$. The ethylene concentration is $x_{\\mathrm{wt}}$.\n$$I(x_{\\mathrm{wt}}, 0) = (1-0)^2 \\left[1 - \\left(\\frac{K_d}{K_d + x_{\\mathrm{wt}}}\\right)^2\\right] = 0.40$$\n$$1 - \\left(\\frac{K_d}{K_d + x_{\\mathrm{wt}}}\\right)^2 = 0.40$$\n$$\\left(\\frac{K_d}{K_d + x_{\\mathrm{wt}}}\\right)^2 = 0.60$$\nTaking the positive square root:\n$$\\frac{K_d}{K_d + x_{\\mathrm{wt}}} = \\sqrt{0.60}$$\nSolving for $x_{\\mathrm{wt}}$:\n$$K_d = \\sqrt{0.60} (K_d + x_{\\mathrm{wt}})$$\n$$K_d(1 - \\sqrt{0.60}) = \\sqrt{0.60} x_{\\mathrm{wt}}$$\n$$x_{\\mathrm{wt}} = K_d \\frac{1 - \\sqrt{0.60}}{\\sqrt{0.60}} = K_d \\left(\\frac{1}{\\sqrt{0.60}} - 1\\right)$$\n\nCase 2: Mixed receptor pool.\nHere, $q=0.30$. The ethylene concentration is $x_{\\mathrm{mix}}$.\n$$I(x_{\\mathrm{mix}}, 0.30) = (1-0.30)^2 \\left[1 - \\left(\\frac{K_d}{K_d + x_{\\mathrm{mix}}}\\right)^2\\right] = 0.40$$\n$$(0.70)^2 \\left[1 - \\left(\\frac{K_d}{K_d + x_{\\mathrm{mix}}}\\right)^2\\right] = 0.40$$\n$$0.49 \\left[1 - \\left(\\frac{K_d}{K_d + x_{\\mathrm{mix}}}\\right)^2\\right] = 0.40$$\n$$1 - \\left(\\frac{K_d}{K_d + x_{\\mathrm{mix}}}\\right)^2 = \\frac{0.40}{0.49}$$\n$$\\left(\\frac{K_d}{K_d + x_{\\mathrm{mix}}}\\right)^2 = 1 - \\frac{0.40}{0.49} = \\frac{0.09}{0.49}$$\nTaking the positive square root:\n$$\\frac{K_d}{K_d + x_{\\mathrm{mix}}} = \\sqrt{\\frac{0.09}{0.49}} = \\frac{0.3}{0.7} = \\frac{3}{7}$$\nSolving for $x_{\\mathrm{mix}}$:\n$$7K_d = 3(K_d + x_{\\mathrm{mix}}) = 3K_d + 3x_{\\mathrm{mix}}$$\n$$4K_d = 3x_{\\mathrm{mix}}$$\n$$x_{\\mathrm{mix}} = \\frac{4}{3}K_d$$\n\nFinally, we compute the fold-shift factor $F$.\n$$F = \\frac{x_{\\mathrm{mix}}}{x_{\\mathrm{wt}}} = \\frac{\\frac{4}{3}K_d}{K_d \\left(\\frac{1}{\\sqrt{0.60}} - 1\\right)} = \\frac{\\frac{4}{3}}{\\frac{1}{\\sqrt{0.60}} - 1}$$\nNow, we calculate the numerical value.\n$$\\sqrt{0.60} \\approx 0.774596669$$\n$$\\frac{1}{\\sqrt{0.60}} \\approx 1.290994449$$\n$$F = \\frac{\\frac{4}{3}}{1.290994449 - 1} = \\frac{1.333333...}{0.290994449...} \\approx 4.581978...$$\nRounding to three significant figures, we get $F \\approx 4.58$.", "answer": "$$\\boxed{4.58}$$", "id": "2566784"}]}